Skip to main content
Erschienen in: Current Fungal Infection Reports 2/2016

04.04.2016 | Current Management of Fungal Infections (RE Lewis, Section Editor)

Impact of New Diagnostic Approaches for Invasive Candidiasis on Antifungal Stewardship

verfasst von: Amelia K. Sofjan, Rachel J. Musgrove, Kevin W. Garey

Erschienen in: Current Fungal Infection Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Invasive candidiasis (IC) including candidemia and deep-seated candidiasis is associated with up to 50 % overall mortality and up to $80,000 in attributable cost (2015 US$). Rapid diagnostic tests (RDTs) for Candida have been developed. However, whether RDTs along with real-time decision support translate to better attainment of stewardship goals—improve clinical outcomes, minimize unintended consequences of antifungal use, and reduce healthcare costs—is unknown. The purpose of this systematic review was to provide an up-to-date review of recently published studies that have assessed how RDTs for IC impact attainment of these goals.

Methods

Three electronic bibliographic databases were searched using a pre-defined search strategy evaluating the impact of RDTs for IC on attainment of antifungal stewardship goals. Quality assessments were performed by two reviewers using established study methodology metrics.

Results and Conclusions

Eight studies were identified of which five had sufficient information to be included in the review. Despite the limitations of the various studies and the different methodologies employed, the studies all produced similar conclusions. Compared to conventional methods and baseline stewardship activities, the integration of RDTs for IC and real-time decision support, mainly through antifungal stewardship, was associated with decreased mortality, more optimal use of antifungals, and reduced healthcare costs. However, larger clinical studies are needed to confirm these trends.
Literatur
2.
Zurück zum Zitat Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2004;39(3):309–17. doi:10.1086/421946.CrossRef Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2004;39(3):309–17. doi:10.​1086/​421946.CrossRef
3.
Zurück zum Zitat Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(8):1110–22. doi:10.1093/cid/cis021.CrossRef Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(8):1110–22. doi:10.​1093/​cid/​cis021.CrossRef
4.
Zurück zum Zitat Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2005;41(9):1232–9. doi:10.1086/496922.CrossRef Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2005;41(9):1232–9. doi:10.​1086/​496922.CrossRef
5.
Zurück zum Zitat Clancy CJ, Nguyen MH. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2013;56(9):1284–92. doi:10.1093/cid/cit006.CrossRef Clancy CJ, Nguyen MH. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2013;56(9):1284–92. doi:10.​1093/​cid/​cit006.CrossRef
6.
Zurück zum Zitat Cobos-Trigueros N, Kaasch AJ, Soriano A, Torres JL, Vergara A, Morata L, et al. Time to positivity and detection of growth in anaerobic blood culture vials predict the presence of Candida glabrata in candidemia: a two-center European cohort study. Journal of Clinical Microbiology. 2014;52(8):3082–4. doi:10.1128/JCM.01198-14.CrossRefPubMedPubMedCentral Cobos-Trigueros N, Kaasch AJ, Soriano A, Torres JL, Vergara A, Morata L, et al. Time to positivity and detection of growth in anaerobic blood culture vials predict the presence of Candida glabrata in candidemia: a two-center European cohort study. Journal of Clinical Microbiology. 2014;52(8):3082–4. doi:10.​1128/​JCM.​01198-14.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Huang L, Zhang YY, Sun LY. Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2013;32(7):917–22. doi:10.1007/s10096-013-1826-8.CrossRef Huang L, Zhang YY, Sun LY. Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2013;32(7):917–22. doi:10.​1007/​s10096-013-1826-8.CrossRef
9.
Zurück zum Zitat Shah DN, Yau R, Weston J, Lasco TM, Salazar M, Palmer HR, et al. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. The Journal of antimicrobial chemotherapy. 2011;66(9):2146–51. doi:10.1093/jac/dkr244.CrossRefPubMed Shah DN, Yau R, Weston J, Lasco TM, Salazar M, Palmer HR, et al. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. The Journal of antimicrobial chemotherapy. 2011;66(9):2146–51. doi:10.​1093/​jac/​dkr244.CrossRefPubMed
10.
Zurück zum Zitat Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006;43(1):25–31. doi:10.1086/504810.CrossRef Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006;43(1):25–31. doi:10.​1086/​504810.CrossRef
11.
12.
Zurück zum Zitat Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance(R)) registry, 2004-2008. Diagnostic microbiology and infectious disease. 2012;74(4):323–31. doi:10.1016/j.diagmicrobio.2012.10.003.CrossRefPubMed Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance(R)) registry, 2004-2008. Diagnostic microbiology and infectious disease. 2012;74(4):323–31. doi:10.​1016/​j.​diagmicrobio.​2012.​10.​003.CrossRefPubMed
13.
Zurück zum Zitat Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). International journal of antimicrobial agents. 2011;38(1):65–9. doi:10.1016/j.ijantimicag.2011.02.016.CrossRefPubMed Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). International journal of antimicrobial agents. 2011;38(1):65–9. doi:10.​1016/​j.​ijantimicag.​2011.​02.​016.CrossRefPubMed
14.
Zurück zum Zitat Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, Booker R, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013;56(12):1724–32. doi:10.1093/cid/cit136.CrossRef Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, Booker R, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013;56(12):1724–32. doi:10.​1093/​cid/​cit136.CrossRef
15.
Zurück zum Zitat Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;59(6):819–25. doi:10.1093/cid/ciu407.CrossRef Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;59(6):819–25. doi:10.​1093/​cid/​ciu407.CrossRef
16.
Zurück zum Zitat Pfaller MA, Castanheira M. Nosocomial candidiasis: antifungal stewardship and the importance of rapid diagnosis. Medical mycology. 2016;54(1):1–22. doi:10.1093/mmy/myv076.PubMed Pfaller MA, Castanheira M. Nosocomial candidiasis: antifungal stewardship and the importance of rapid diagnosis. Medical mycology. 2016;54(1):1–22. doi:10.​1093/​mmy/​myv076.PubMed
17.
Zurück zum Zitat Fortun J, Meije Y, Buitrago MJ, Gago S, Bernal-Martinez L, Peman J, et al. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. The Journal of antimicrobial chemotherapy. 2014;69(11):3134–41. doi:10.1093/jac/dku225.CrossRefPubMed Fortun J, Meije Y, Buitrago MJ, Gago S, Bernal-Martinez L, Peman J, et al. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. The Journal of antimicrobial chemotherapy. 2014;69(11):3134–41. doi:10.​1093/​jac/​dku225.CrossRefPubMed
18.
Zurück zum Zitat Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015;60(6):892–9. doi:10.1093/cid/ciu959.CrossRef Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015;60(6):892–9. doi:10.​1093/​cid/​ciu959.CrossRef
19.
Zurück zum Zitat Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2012;69(21):1910–4. doi:10.2146/ajhp110604.CrossRef Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2012;69(21):1910–4. doi:10.​2146/​ajhp110604.CrossRef
20.•
Zurück zum Zitat Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013;57(9):1237–45. doi:10.1093/cid/cit498. This pre-post quasi-experimental study implemented MALDI-TOF and real-time antifungal stewardship in patients with candidemia and demonstrated a trend for faster time to active therapy and a lower mortality rate compared to conventional methods and baseline stewardship activities.CrossRef Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013;57(9):1237–45. doi:10.​1093/​cid/​cit498. This pre-post quasi-experimental study implemented MALDI-TOF and real-time antifungal stewardship in patients with candidemia and demonstrated a trend for faster time to active therapy and a lower mortality rate compared to conventional methods and baseline stewardship activities.CrossRef
21.••
Zurück zum Zitat Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, et al. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015;61(7):1071–80. doi:10.1093/cid/civ447. This open-label randomized controlled trial suggested that electronic templated comments can be used to communicate results of a rapid diagnostic test and deliver straightforward recommendations to clinicians, such as discontinuing treatment of contaminants and escalating therapy in patients with positive blood cultures. This was the first study to show that real-time antifungal stewardship is not the only effective form of support that can aid clinicians in acting on the results of a rapid diagnostic test.CrossRef Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, et al. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015;61(7):1071–80. doi:10.​1093/​cid/​civ447. This open-label randomized controlled trial suggested that electronic templated comments can be used to communicate results of a rapid diagnostic test and deliver straightforward recommendations to clinicians, such as discontinuing treatment of contaminants and escalating therapy in patients with positive blood cultures. This was the first study to show that real-time antifungal stewardship is not the only effective form of support that can aid clinicians in acting on the results of a rapid diagnostic test.CrossRef
22.
Zurück zum Zitat Holtzman C, Whitney D, Barlam T, Miller NS. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. Journal of clinical microbiology. 2011;49(4):1581–2. doi:10.1128/jcm.02461-10.CrossRefPubMedPubMedCentral Holtzman C, Whitney D, Barlam T, Miller NS. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. Journal of clinical microbiology. 2011;49(4):1581–2. doi:10.​1128/​jcm.​02461-10.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Carver PL, Lin SW, DePestel DD, Newton DW. Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital. Journal of clinical microbiology. 2008;46(7):2381–3. doi:10.1128/jcm.00801-08.CrossRefPubMedPubMedCentral Carver PL, Lin SW, DePestel DD, Newton DW. Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital. Journal of clinical microbiology. 2008;46(7):2381–3. doi:10.​1128/​jcm.​00801-08.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Dellit TH, Owens RC, McGowan Jr JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007;44(2):159–77. doi:10.1086/510393.CrossRef Dellit TH, Owens RC, McGowan Jr JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007;44(2):159–77. doi:10.​1086/​510393.CrossRef
27.
Zurück zum Zitat Ofman JJ, Sullivan SD, Neumann PJ, Chiou CF, Henning JM, Wade SW, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. Journal of managed care pharmacy : JMCP. 2003;9(1):53–61.CrossRefPubMed Ofman JJ, Sullivan SD, Neumann PJ, Chiou CF, Henning JM, Wade SW, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. Journal of managed care pharmacy : JMCP. 2003;9(1):53–61.CrossRefPubMed
28.
Zurück zum Zitat Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. Jama. 2001;285(15):1992–5.CrossRefPubMed Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. Jama. 2001;285(15):1992–5.CrossRefPubMed
30.
Zurück zum Zitat Stone NR, Gorton RL, Barker K, Ramnarain P, Kibbler CC. Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact. Journal of clinical microbiology. 2013;51(4):1301–2. doi:10.1128/JCM.00028-13.CrossRefPubMedPubMedCentral Stone NR, Gorton RL, Barker K, Ramnarain P, Kibbler CC. Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact. Journal of clinical microbiology. 2013;51(4):1301–2. doi:10.​1128/​JCM.​00028-13.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Whittier S, Della-Latta P. Clinical relevance of rapid identification of candidemia using a dual color PNA FISH assay. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2014;21S:212.CrossRef Whittier S, Della-Latta P. Clinical relevance of rapid identification of candidemia using a dual color PNA FISH assay. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2014;21S:212.CrossRef
32.••
Zurück zum Zitat Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, et al. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. The Annals of pharmacotherapy. 2014;48(6):683–90. doi:10.1177/1060028014529928. ̇This 5000-person Monte Carlo simulation study demonstrated that utilizing T2Candida in patients at high risk for candidemia and receiving empiric echinocandins can result in faster time to discontinuing unnecessary antifungal therapy and substantial cost savings.CrossRefPubMed Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, et al. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. The Annals of pharmacotherapy. 2014;48(6):683–90. doi:10.​1177/​1060028014529928​. ̇This 5000-person Monte Carlo simulation study demonstrated that utilizing T2Candida in patients at high risk for candidemia and receiving empiric echinocandins can result in faster time to discontinuing unnecessary antifungal therapy and substantial cost savings.CrossRefPubMed
33.•
Zurück zum Zitat Bilir SP, Ferrufino CP, Pfaller MA, Munakata J. The economic impact of rapid Candida species identification by T2Candida among high-risk patients. Future microbiology. 2015;10(7):1133–44. doi:10.2217/fmb.15.29. ̈This 1-year decision-tree model conducted from a hospital’s perspective demonstrated that utilizing T2Candida in patients at high-risk for candidemia can reduce morality rate and generate substantial total cost savings.CrossRefPubMed Bilir SP, Ferrufino CP, Pfaller MA, Munakata J. The economic impact of rapid Candida species identification by T2Candida among high-risk patients. Future microbiology. 2015;10(7):1133–44. doi:10.​2217/​fmb.​15.​29. ̈This 1-year decision-tree model conducted from a hospital’s perspective demonstrated that utilizing T2Candida in patients at high-risk for candidemia can reduce morality rate and generate substantial total cost savings.CrossRefPubMed
34.
Zurück zum Zitat Harris AD, Lautenbach E, Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005;41(1):77–82. doi:10.1086/430713.CrossRef Harris AD, Lautenbach E, Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005;41(1):77–82. doi:10.​1086/​430713.CrossRef
36.
Zurück zum Zitat Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled clinical trials. 1996;17(1):1–12.CrossRefPubMed Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled clinical trials. 1996;17(1):1–12.CrossRefPubMed
37.
Zurück zum Zitat Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lincalis DP, et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. Journal of clinical microbiology. 2006;44(9):3381–3. doi:10.1128/jcm.00751-06.CrossRefPubMedPubMedCentral Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lincalis DP, et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. Journal of clinical microbiology. 2006;44(9):3381–3. doi:10.​1128/​jcm.​00751-06.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Archives of pathology & laboratory medicine. 2013;137(9):1247–54. doi:10.5858/arpa.2012-0651-OA.CrossRef Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Archives of pathology & laboratory medicine. 2013;137(9):1247–54. doi:10.​5858/​arpa.​2012-0651-OA.CrossRef
39.
Zurück zum Zitat Pogue JM, Mynatt RP, Marchaim D, Zhao JJ, Barr VO, Moshos J, et al. Automated alerts coupled with antimicrobial stewardship intervention lead to decreases in length of stay in patients with gram-negative bacteremia. Infection control and hospital epidemiology. 2014;35(2):132–8. doi:10.1086/674849.CrossRefPubMed Pogue JM, Mynatt RP, Marchaim D, Zhao JJ, Barr VO, Moshos J, et al. Automated alerts coupled with antimicrobial stewardship intervention lead to decreases in length of stay in patients with gram-negative bacteremia. Infection control and hospital epidemiology. 2014;35(2):132–8. doi:10.​1086/​674849.CrossRefPubMed
40.
Zurück zum Zitat Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. The Journal of infection. 2014;69(3):216–25. doi:10.1016/j.jinf.2014.05.005.CrossRefPubMed Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. The Journal of infection. 2014;69(3):216–25. doi:10.​1016/​j.​jinf.​2014.​05.​005.CrossRefPubMed
41.
Zurück zum Zitat Box MJ, Sullivan EL, Ortwine KN, Parmenter MA, Quigley MM, Aguilar-Higgins LM, et al. Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system. Pharmacotherapy. 2015;35(3):269–76. doi:10.1002/phar.1557.CrossRefPubMed Box MJ, Sullivan EL, Ortwine KN, Parmenter MA, Quigley MM, Aguilar-Higgins LM, et al. Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system. Pharmacotherapy. 2015;35(3):269–76. doi:10.​1002/​phar.​1557.CrossRefPubMed
42.
Zurück zum Zitat Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010;51(9):1074–80. doi:10.1086/656623.CrossRef Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010;51(9):1074–80. doi:10.​1086/​656623.CrossRef
43.
Zurück zum Zitat Antworth A, Collins CD, Kunapuli A, Klein K, Carver P, Gandhi T, et al. Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia. Pharmacotherapy. 2013;33(2):137–43. doi:10.1002/phar.1186.CrossRefPubMed Antworth A, Collins CD, Kunapuli A, Klein K, Carver P, Gandhi T, et al. Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia. Pharmacotherapy. 2013;33(2):137–43. doi:10.​1002/​phar.​1186.CrossRefPubMed
Metadaten
Titel
Impact of New Diagnostic Approaches for Invasive Candidiasis on Antifungal Stewardship
verfasst von
Amelia K. Sofjan
Rachel J. Musgrove
Kevin W. Garey
Publikationsdatum
04.04.2016
Verlag
Springer US
Erschienen in
Current Fungal Infection Reports / Ausgabe 2/2016
Print ISSN: 1936-3761
Elektronische ISSN: 1936-377X
DOI
https://doi.org/10.1007/s12281-016-0257-2

Weitere Artikel der Ausgabe 2/2016

Current Fungal Infection Reports 2/2016 Zur Ausgabe

Clinical Mycology Lab Issues (K Lagrou, Section Editor)

Next-Generation Sequencing in the Mycology Lab

Clinical Mycology Lab Issues (K Lagrou, Section Editor)

Evolution of Cryptococcal Antigen Testing: What Is New?

Clinical Mycology Lab Issues (K Lagrou, Section Editor)

Therapeutic Drug Monitoring of Posaconazole: an Update

Clinical Mycology Lab Issues (K Lagrou, Section Editor)

Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.